Bellus Health Gross Profit

Bellus Health posts a gross profit of $-2.2B as of September 2023. That compares with $-920M in the prior-year period — down 141.8% year over year. That is below the Healthcare sector average of $67B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Bellus Health's gross profit was $-920M. The latest reading is $-2.2B — a 141.8% year-over-year decrease (period ending September 2023). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a gross profit near $67B is typical. Bellus Health's $-2.2B is lower that level. That is roughly 103.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Gross Profit is one piece of Bellus Health's financial statement story. At $-2.2B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BLU's gross profit usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $67B), and (3) consistency with growth and profitability. This page covers the first two; Bellus Health's other metric pages and overview cover the third.